Newbury Pharmaceuticals ABFNSE Newbury Pharmaceuticals Stock Report

Newbury Pharmaceuticals AB is a hybrid pharmaceutical company, which engages in specialty prescription drugs inn the Scandinavian markets. The company is headquartered in Lund, Skane. The company went IPO on 2022-02-04. The Company’s existing portfolio is focused on the Scandinavian market and consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology.